Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

CADLCADL
4 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in CANDEL THERAPEUTICS INC

WELLINGTON MANAGEMENT GROUP LLP holds 205,745 shares of CADL (CANDEL THERAPEUTICS INC), worth $2.1M as of 2026-Q2. This is a new position. CADL represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$2.1M

Current Shares

205,745

Total Value Change

+$1.7M

Total Shares Change

+119,498

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
205,745
-
$2.1M0.0%$10.30
36
2025-Q4
Exited
0
-100.0%
$00.0%$5.71
0
2025-Q3
Increased
137,888
+59.9%
$703,2290.0%$5.40
35
2025-Q2
New
86,247
-
$436,4100.0%$4.90
33

Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used